Literature DB >> 8351543

Effect of anabolic steroids on HIV-related wasting myopathy.

J R Berger1, L Pall, D Winfield.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) is frequently associated with weakness and muscle wasting, referred to as HIV-1 wasting myopathy. This illness, often observed in the advanced stages of acquired immunodeficiency syndrome (AIDS), responds poorly to therapeutic intervention. We describe the cases of three AIDS patients with HIV-1 wasting myopathy who had a favorable response to anabolic steroids as evidenced by an improvement in strength, muscle bulk, body weight, and sense of well-being.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8351543     DOI: 10.1097/00007611-199308000-00003

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

1.  Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.

Authors:  S Bhasin; T W Storer; M Javanbakht; N Berman; K E Yarasheski; J Phillips; M Dike; I Sinha-Hikim; R Shen; R D Hays; G Beall
Journal:  JAMA       Date:  2000-02-09       Impact factor: 56.272

Review 2.  Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update.

Authors:  M S Bahrke; C E Yesalis; J E Wright
Journal:  Sports Med       Date:  1996-12       Impact factor: 11.136

Review 3.  Therapeutic options for HIV-associated bodyweight loss. A risk-benefit analysis.

Authors:  V Stosor; J V Roenn
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

Review 4.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 5.  [Glucocorticoids and androgens for treatment of tiredness and weakness in palliative care patients : a systematic review].

Authors:  A Thiem; R Rolke; L Radbruch
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

6.  Simple Synthesis of 17-β-O-hemisuccinate of Stanozolol for Immunoanalytical Methods.

Authors:  Silvana Casati; Roberta Ottria; Pierangela Ciuffreda
Journal:  Molecules       Date:  2020-04-26       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.